Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research1

FiltersClear all

Status

Recruiting1

Study type

Expanded access1
Interventional9

Phase

Not reported1

Investigator

Gaurav Varma1

Department

Medicine1

Condition

Lymphoma1
Multiple Myeloma5
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Recurrence2
Burkitt Lymphoma1

Intervention type

Biological1

Sponsor type

Industry1

Start date

to

Expanded access×Lymphoma×Clear all

Showing 1–1 of 1 studySort:

RecruitingExpanded accessNCT03601442 ↗
Managed Access Programs for CTL019, Tisagenlecleucel

Show all 15

Show fewer

COVID-191
Hyperlipoproteinemia Type I1
Infections1
Leukemia1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Lymphoma, Follicular1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Mantle-Cell1
Melanoma1
Pulmonary Arterial Hypertension1

PI

Intervention: Biological: CTL019
Dates: Started Dec 2019
Sponsor: Novartis Pharmaceuticals Corporation

LymphomaLeukemiaOff-label Indications